Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.90 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL29051415 | 1.00 | CA4 (0.90) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Citric Acid SCHEMBL27887857 | 0.97 | CA4 (0.85) | CA4CASP1 | |
| Citric Acid SCHEMBL372534 | 0.97 | CA4 (0.94) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Citric Acid SCHEMBL6692872 | 0.97 | CA4 (0.94) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Citric Acid SCHEMBL372244 | 0.97 | CA4 (0.94) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Citric Acid SCHEMBL25212993 | 0.97 | CA4 (0.94) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Citric Acid SCHEMBL260176 | 0.97 | CA4 (0.94) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Citric Acid SCHEMBL8440714 | 0.97 | CA4 (0.94) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Citric Acid SCHEMBL20917176 | 0.97 | CA4 (0.94) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Citric Acid SCHEMBL8066143 | 0.97 | CA4 (0.94) | CA4CASP1FFAR3HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110501498-A | A kind of p16 immunologic combined detection reagent kit | SHENZHEN SENYING BIO TECH CO LTD | 2019-11-26 | — | — | CN | disclosed |
| CN-208560482-U | Dustbin and Medical garbage bin with sterilizing | 杭州电子科技大学 | 2019-03-01 | — | — | CN | disclosed |
| CN-108622577-A | Dustbin with sterilizing and Medical garbage bin | 杭州电子科技大学 | 2018-10-09 | — | — | CN | disclosed |
| US-20170348391-A1 | MULTIPLE-VARIABLE IL-2 DOSE REGIMEN FOR TREATING IMMUNE DISORDERS | DANA-FARBER CANCER INSTITUTE, INC. | 2017-12-07 | — | — | US | disclosed |
| US-20160220599-A1 | NOVEL LINCRNA AND INTERFERING NUCLEIC ACID MOLECULES, COMPOSITIONS AND METHODS AND USES THEREOF FOR REGULATING ANGIOGENESIS AND RELATED CONDITIONS | ST. MICHAEL'S HOSPITAL (CA) | 2016-08-04 | — | — | US | disclosed |
| US-20130232643-A1 | Methods in Increasing Grain Value by Improving Grain Yield and Quality | BASF PLANT SCIENCE GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-20130198911-A1 | Process for the Production of Fine Chemicals | BASF PLANT SCIENCE GMBH (DE) | 2013-08-01 | — | — | US | disclosed |
| EP-2207809-B1 | HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR ANTIGEN BINDING PROTEINS | U3 PHARMA GMBH (DE) | 2013-07-03 | — | — | EP | disclosed |
| EP-2570432-A1 | Stabilized anti-respiratory syncytial virus (RSV) antibody formulations | MEDIMMUNE, INC. (US) | 2013-03-20 | — | — | EP | disclosed |
| WO-2010147273-A2 | METHOD FOR SCREENING AGENTS TO TREAT REPRODUCTIVE FUNCTION DISORDERS CAUSED BY ALCOHOL EXPOSURE | 경상대학교산학협력단 (KR) | 2010-12-23 | — | — | WO | disclosed |
| US-20030022195-A1 | 59914 and 59921, choline transporters and uses therefor | MILLENNIUM PHARMACEUTICALS, INC. | 2003-01-30 | — | — | US | disclosed |
| US-20020108132-A1 | Production of a monoclonal antibody by a transgenic chicken | AVIGENICS INC. | 2002-08-08 | — | — | US | disclosed |
| WO-2002055713-A2 | 58848, A HUMAN PROTEIN KINASE FAMILY MEMBER AND USES THEREFOR | MILLENNIUM PHARM INC (US) | 2002-07-18 | — | — | WO | disclosed |
| US-6329171-B1 | A NUCLEOTIDE SEQUENCE; DIAGNOSIS AND THERAPY FOR EATING DISORDERS, KIDNEY TUBULAR DEFECTS, DIABETES, UREMIA, NEUROMUSCULAR DISEASES, BURN INJURIES, SEPSIS, CANCER, CACHEXIA AND HYPERTHYROIDISM | MILLENNIUM PHARMACEUTICALS, INC. | 2001-12-11 | — | — | US | disclosed |
| US-6271197-B1 | ADMINISTERING A GERANYLGERANYL TRANSFERASE INHIBITOR | GPC-BIOTECH INC. | 2001-08-07 | — | — | US | disclosed |
| US-5759609-A | CAN BE STORED FROZEN IN AN UNWHIPPED STATE FOR AND INDEFINITE PERIOD OF TIME | RICH PRODUCTS CORPORATION (US) | 1998-06-02 | — | — | US | disclosed |
| EP-0624163-A1 | CYCLIC CALCITONIN DERIVATIVES AND METHOD FOR THEIR PRODUCTION | Smithkline Beecham Farmaceutici S.p.A. (IT) | 1994-11-17 | — | — | EP | disclosed |
| EP-0607229-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A CALCITONIN, A GLYCYRRHIZINATE AS ABSORPTION ENHANCER AND BENZYL | Smithkline Beecham Farmaceutici S.p.A. (IT) | 1994-07-27 | — | — | EP | disclosed |
| WO-1993015106-A1 | CYCLIC CALCITONINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION | SMITHKLINE BEECHAM FARMACEUTICI S.P.A. (IT) | 1993-08-05 | — | — | WO | disclosed |
| WO-1993006854-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A CALCITONIN, A GLYCYRRHIZINATE AS ABSORPTION ENHANCER AND BENZYL | SMITHKLINE BEECHAM FARMACEUTICI S.P.A. (IT) | 1993-04-15 | — | — | WO | disclosed |